HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
November 01, 2021 00:15 ET | HUTCHMED (China) Limited
— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and CALYPSO — — In CALYPSO, savolitinib and IMFINZI® combination demonstrated a 57%...
20170406 Telix Logo.png
FDA Approves Phase II Kidney Cancer Therapy Study
September 13, 2021 18:41 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
22157.jpg
Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics
August 20, 2021 06:08 ET | Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Global $3.32 Bn Interventional Oncology Devices Market to 2030: Embolization Devices, Ablation Devices, & Support Devices
July 16, 2021 05:53 ET | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global $136.7 Billion Oncology Market to 2025
October 30, 2020 03:13 ET | Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Oncology Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Oncology Market size was valued at $136.7...
20170406 Telix Logo.png
First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
October 22, 2020 01:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...
20170406 Telix Logo.png
First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan
August 17, 2020 20:00 ET | Telix Pharmaceuticals Limited
TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that...
NS-Horizontal.png
Napoli Shkolnik PLLC Files A Class Action Lawsuit For Love Canal, New York
February 16, 2018 16:31 ET | Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - February 16, 2018) - Napoli Shkolnik has filed a class action lawsuit against the City of Niagara Falls, the Niagara Falls Water Board, Occidental Petroleum Corporation...
Logo.jpg
New Study Finds That Robotically Assisted Surgery for Kidney Cancer Increases Access to Partial Versus Radical Nephrectomy, Reducing Mortality, Renal Failure and Long-Term Costs
February 03, 2015 11:00 ET | Intuitive Surgical, Inc.
SUNNYVALE, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- A new study, published in the February issue of Health Affairs, found that in terms of quality-adjusted life-years gained, the benefits of...
Diagnostic Advances in Cancer Research Utilizing Raman Molecular Imaging to be Presented at USCAP
February 15, 2011 11:32 ET | ChemImage
PITTSBURGH, Pa., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular...